Forecast & Rating3 analysts currently cover Xtant Med, of which 3 give a positive rating. The average price target is $1.03, about 187.8% upside from the current price of $0.36. Coverage is limited, so the data is for reference only. Data as of Sep 2, 2026; this does not constitute investment advice.
Sep 2, 2026Price forecast
$1.03187.76%
Forecast & RatingStrong buy
3analysts
- Strong buy66.67%
- Buy33.33%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
Target price forecast
Forecast dateSep 28, 2026
Forecast met9.5%
Stock price$0.36
Avg. target$1.5
High target$2
Low target$2
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.